JP2022177119A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022177119A5 JP2022177119A5 JP2022144243A JP2022144243A JP2022177119A5 JP 2022177119 A5 JP2022177119 A5 JP 2022177119A5 JP 2022144243 A JP2022144243 A JP 2022144243A JP 2022144243 A JP2022144243 A JP 2022144243A JP 2022177119 A5 JP2022177119 A5 JP 2022177119A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- administration
- drug
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025044178A JP2025098099A (ja) | 2019-12-06 | 2025-03-19 | ブルトン型チロシンキナーゼ阻害剤の投薬 |
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962944674P | 2019-12-06 | 2019-12-06 | |
| US62/944,674 | 2019-12-06 | ||
| US202063077996P | 2020-09-14 | 2020-09-14 | |
| US63/077,996 | 2020-09-14 | ||
| US202063109698P | 2020-11-04 | 2020-11-04 | |
| US63/109,698 | 2020-11-04 | ||
| PCT/US2020/063089 WO2021113497A1 (en) | 2019-12-06 | 2020-12-03 | Dosing of a bruton's tyrosine kinase inhibitor |
| JP2021557408A JP7142173B2 (ja) | 2019-12-06 | 2020-12-03 | ブルトン型チロシンキナーゼ阻害剤の投薬 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557408A Division JP7142173B2 (ja) | 2019-12-06 | 2020-12-03 | ブルトン型チロシンキナーゼ阻害剤の投薬 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025044178A Division JP2025098099A (ja) | 2019-12-06 | 2025-03-19 | ブルトン型チロシンキナーゼ阻害剤の投薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022177119A JP2022177119A (ja) | 2022-11-30 |
| JP2022177119A5 true JP2022177119A5 (https=) | 2023-10-31 |
| JP7654604B2 JP7654604B2 (ja) | 2025-04-01 |
Family
ID=73854977
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557408A Active JP7142173B2 (ja) | 2019-12-06 | 2020-12-03 | ブルトン型チロシンキナーゼ阻害剤の投薬 |
| JP2022144243A Active JP7654604B2 (ja) | 2019-12-06 | 2022-09-12 | ブルトン型チロシンキナーゼ阻害剤の投薬 |
| JP2025044178A Pending JP2025098099A (ja) | 2019-12-06 | 2025-03-19 | ブルトン型チロシンキナーゼ阻害剤の投薬 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557408A Active JP7142173B2 (ja) | 2019-12-06 | 2020-12-03 | ブルトン型チロシンキナーゼ阻害剤の投薬 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025044178A Pending JP2025098099A (ja) | 2019-12-06 | 2025-03-19 | ブルトン型チロシンキナーゼ阻害剤の投薬 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12551463B2 (https=) |
| EP (1) | EP4069219A1 (https=) |
| JP (3) | JP7142173B2 (https=) |
| KR (2) | KR20230127372A (https=) |
| CN (1) | CN115175677A (https=) |
| AU (2) | AU2020397034B2 (https=) |
| BR (1) | BR112022009716A2 (https=) |
| IL (1) | IL292882A (https=) |
| MX (1) | MX2022006631A (https=) |
| WO (1) | WO2021113497A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117285467A (zh) | 2018-07-31 | 2023-12-26 | 罗索肿瘤学公司 | 喷雾干燥的分散体和制剂 |
| JP7142173B2 (ja) * | 2019-12-06 | 2022-09-26 | ロクソ オンコロジー， インコーポレイテッド | ブルトン型チロシンキナーゼ阻害剤の投薬 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2526933T3 (en) | 2006-09-22 | 2015-05-18 | Pharmacyclics Inc | Inhibitors of Bruton's tyrosine kinase |
| KR101668574B1 (ko) | 2012-11-02 | 2016-10-24 | 화이자 인코포레이티드 | 브루톤 티로신 키나제 억제제 |
| US9717745B2 (en) | 2015-03-19 | 2017-08-01 | Zhejiang DTRM Biopharma Co. Ltd. | Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases |
| CN114716381B (zh) | 2015-12-16 | 2025-03-11 | 洛克索肿瘤学股份有限公司 | 可用作激酶抑制剂的化合物 |
| WO2017132474A1 (en) | 2016-01-30 | 2017-08-03 | Newave Pharmaceutical Inc. | Bcl-2 inhibitors |
| US10829488B2 (en) | 2016-08-05 | 2020-11-10 | The Regents Of The University Of Michigan | N-(phenylsulfonyl)benzamides and related compounds as bcl-2 inhibitors |
| EP3565815B1 (en) | 2017-01-07 | 2024-03-13 | Fochon Pharmaceuticals, Ltd. | Compounds as bcl-2-selective apoptosis-inducing agents |
| EP3612531B1 (en) | 2017-04-18 | 2022-08-24 | Shanghai Fochon Pharmaceutical Co., Ltd. | Apoptosis-inducing agents |
| JP2020528061A (ja) | 2017-07-26 | 2020-09-17 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | ＢＥＴ阻害剤、Ｂｃｌ−２阻害剤及び抗ＣＤ２０抗体を用いた併用療法 |
| KR20200108301A (ko) | 2018-01-10 | 2020-09-17 | 리커리엄 아이피 홀딩스, 엘엘씨 | 벤즈아미드 화합물 |
| SG11202009933WA (en) | 2018-04-29 | 2020-11-27 | Beigene Ltd | Bcl-2 INHIBITORS |
| CN117285467A (zh) | 2018-07-31 | 2023-12-26 | 罗索肿瘤学公司 | 喷雾干燥的分散体和制剂 |
| JP7142173B2 (ja) * | 2019-12-06 | 2022-09-26 | ロクソ オンコロジー， インコーポレイテッド | ブルトン型チロシンキナーゼ阻害剤の投薬 |
-
2020
- 2020-12-03 JP JP2021557408A patent/JP7142173B2/ja active Active
- 2020-12-03 IL IL292882A patent/IL292882A/en unknown
- 2020-12-03 KR KR1020237028538A patent/KR20230127372A/ko active Pending
- 2020-12-03 KR KR1020227022407A patent/KR20220100992A/ko not_active Ceased
- 2020-12-03 AU AU2020397034A patent/AU2020397034B2/en active Active
- 2020-12-03 US US17/782,758 patent/US12551463B2/en active Active
- 2020-12-03 CN CN202080095816.0A patent/CN115175677A/zh active Pending
- 2020-12-03 EP EP20825385.6A patent/EP4069219A1/en active Pending
- 2020-12-03 WO PCT/US2020/063089 patent/WO2021113497A1/en not_active Ceased
- 2020-12-03 MX MX2022006631A patent/MX2022006631A/es unknown
- 2020-12-03 BR BR112022009716A patent/BR112022009716A2/pt unknown
-
2022
- 2022-09-12 JP JP2022144243A patent/JP7654604B2/ja active Active
-
2024
- 2024-02-26 AU AU2024201263A patent/AU2024201263B2/en active Active
-
2025
- 2025-03-19 JP JP2025044178A patent/JP2025098099A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022180461A5 (https=) | ||
| JP2024074963A5 (https=) | ||
| JP2022537551A5 (https=) | ||
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| CN107260695A (zh) | 硝唑尼特的控制释放药物剂型 | |
| JP2010522135A (ja) | 医薬組成物 | |
| JP2018507243A5 (https=) | ||
| JP2021504384A5 (https=) | ||
| JP2023552700A5 (https=) | ||
| JP2024507810A5 (https=) | ||
| JP2022177119A5 (https=) | ||
| RU2010109359A (ru) | Азитромицин для лечения кожных заболеваний | |
| MX2024010637A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JP2024527023A5 (https=) | ||
| JP2024517085A5 (https=) | ||
| JP2023522415A5 (https=) | ||
| JP2016505050A5 (https=) | ||
| JP2022553888A5 (https=) | ||
| US20260102370A1 (en) | Methods of treating obesity in responder and non-responder populations | |
| JP2004091473A (ja) | 色素沈着改善治療薬 | |
| IL292882A (en) | Dosage of Bruton's tyrosine kinase inhibitor | |
| CN115607545B (zh) | 依达拉奉在自闭症谱系障碍治疗中的应用 | |
| CN113557016A (zh) | 衣壳组装调节剂固体配制品 | |
| JP2025511402A5 (https=) | ||
| JP2025511401A5 (https=) |